118 related articles for article (PubMed ID: 22188463)
1. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS).
Tas F; Sen F; Keskin S; Kilic L
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):789-92. PubMed ID: 22188463
[TBL] [Abstract][Full Text] [Related]
2. Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma.
Brambilla L; Miedico A; Ferrucci S; Romanelli A; Brambati M; Vinci M; Tedeschi L; Boneschi V
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1090-4. PubMed ID: 16987264
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
Remick SC; Reddy M; Ekman K; Vyzula R; Hilstro J; Horton J
J Infus Chemother; 1996; 6(2):92-6. PubMed ID: 8809657
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
[TBL] [Abstract][Full Text] [Related]
5. Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study.
Di Lorenzo G; Di Trolio R; Montesarchio V; Palmieri G; Nappa P; Delfino M; De Placido S; Dezube BJ
Cancer; 2008 Mar; 112(5):1147-52. PubMed ID: 18098221
[TBL] [Abstract][Full Text] [Related]
6. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients.
Brambilla L; Bellinvia M; Tourlaki A; Scoppio B; Gaiani F; Boneschi V
Br J Dermatol; 2010 Apr; 162(4):854-9. PubMed ID: 19995366
[TBL] [Abstract][Full Text] [Related]
7. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
Paredes J; Kahn JO; Tong WP; Feldstein ML; Lin S; Bennett JM; Metroka CE; Ratner L; Krown SE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):138-44. PubMed ID: 7749790
[TBL] [Abstract][Full Text] [Related]
8. Classic Kaposi's sarcoma with colonic involvement: a rare presentation with successful treatment with oral etoposide.
Tas F; Keskin S; Yegen G; Gozubuyukoglu N
J Cancer Res Ther; 2012; 8(1):112-3. PubMed ID: 22531526
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
Zidan J; Robenstein W; Abzah A; Taman S
Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
[TBL] [Abstract][Full Text] [Related]
10. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
[TBL] [Abstract][Full Text] [Related]
12. Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.
Di Monta G; Caracò C; Benedetto L; La Padula S; Marone U; Tornesello ML; Buonaguro FM; Simeone E; Ascierto PA; Mozzillo N
Eur J Surg Oncol; 2014 Jan; 40(1):61-6. PubMed ID: 24075826
[TBL] [Abstract][Full Text] [Related]
13. Successful Treatment of a 92-Year-Old Classic Kaposi's Sarcoma Man With Ultra-Low Dose Oral Etoposide.
Tas F; Sakar B
J Oncol Pharm Pract; 2022 Oct; 28(7):1671-1673. PubMed ID: 35105224
[TBL] [Abstract][Full Text] [Related]
14. [Prolonged oral etoposide therapy in advanced stage lung cancer].
Bozóky G; Ruby E; Góhér I; Mohos A; Lengyel M
Orv Hetil; 1997 Jul; 138(28):1791-5. PubMed ID: 9280873
[TBL] [Abstract][Full Text] [Related]
15. Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study.
Rose PG; Blessing JA; Soper JT; Barter JF
Gynecol Oncol; 1998 Aug; 70(2):267-71. PubMed ID: 9740703
[TBL] [Abstract][Full Text] [Related]
16. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
Brambilla L; Romanelli A; Bellinvia M; Ferrucci S; Vinci M; Boneschi V; Miedico A; Tedeschi L
Br J Dermatol; 2008 Jun; 158(6):1339-44. PubMed ID: 18363766
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
Baskan EB; Tunali S; Adim SB; Kiyici M; Ali R
Int J Dermatol; 2006 Dec; 45(12):1441-3. PubMed ID: 17184252
[No Abstract] [Full Text] [Related]
19. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
[TBL] [Abstract][Full Text] [Related]
20. Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index.
Sprinz E; Caldas AP; Mans DR; Cancela A; DiLeone L; Dalla Costa T; Schwartsmann G
Am J Clin Oncol; 2001 Apr; 24(2):177-84. PubMed ID: 11319295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
